CEE 03320
Alternative Names: CEE 03-320; CEE 320; NNC 220215Latest Information Update: 11 Aug 2005
At a glance
- Originator Novo Nordisk
- Developer CeNeS Pharmaceuticals
- Class Antipsychotics; Sleep disorder therapies; Small molecules
- Mechanism of Action Dopamine D1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Schizophrenia; Sleep disorders; Substance-related disorders
Most Recent Events
- 11 Aug 2005 Discontinued - Preclinical for Schizophrenia in Denmark (unspecified route)
- 11 Aug 2005 Discontinued - Preclinical for Sleep disorders in United Kingdom (unspecified route)
- 11 Aug 2005 Discontinued - Preclinical for Substance-related disorders in United Kingdom (unspecified route)